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Abstract
Background:Oxytocin (OXT) is critically involved in the regulation of attachment and interpersonal function. In this study,
emotional children’s movies were used to stimulate OXT secretion in patients with schizophrenia and healthy controls
(HCs). Furthermore, associations of OXT levels with measures of attachment style (Psychosis Attachment Measure),
childhood adversity (Childhood Trauma Questionnaire) and symptom severity [Positive and Negative Syndrome Scale
(PANSS)] were considered.Methods: In 35 patients with schizophrenia and 35 matched HCs, radioimmunoassay with sample
extraction was used to determine OXT plasma levels before and after viewing of movie scenes portraying emotional
bonding and loss and compared to a non-emotional condition. Results:Statistical analysis indicated lower baseline OXT
levels in female patients than in all other groups. OXT reactivity during emotional movies was significantly higher in
patients when compared to HCs. OXT reactivity during the control movie related to PANSS ‘general psychopathology’. No
significant associations appeared between baseline or induced OXT levels and other PANSS subscales, attachment style or
childhood adversity in patients. Conclusions:Our findings suggest differences of baseline OXT and a higher OXT reactivity
toward strong emotional stimuli in patients with schizophrenia, suggesting a role of OXT as a gender- and
context-dependent modulator of socio-emotional function.
Key words: schizophrenia; oxytocin; emotion induction; attachment; trauma
Introduction
In recent decades, disturbances of empathy and emotional
responsivity have gathered increasing attention in schizophre-
nia research. A reduced capacity to emotionally resonate with
others, to understand and to regulate other induced feelings and
relationship distressmight complicate the formation of intimate
bonds. In addition, individuals suffering from psychotic disor-
ders are often burdened with substantial childhood adversity
and may lack stable attachment experiences (Berry et al., 2008).
The spectrum of attachment-related dysfunctions, including
conditions like autism, borderline personality disorder or
schizophrenia, has been consistently linked to the oxytocinergic
system. Oxytocin (OXT), a neurohypophyseal hormone and
neurotransmitter, is considered to be an important modulator
of social cognition and empathy (Domes et al., 2007; Bartz et al.,
2011). Its prosocial effects have consistently been reported from
studies investigating mother–infant (Feldman et al., 2007) and
pair bonding (Young and Wang, 2004), attachment (Buchheim
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(Kéri and Kiss, 2011). De Dreu and Kret (2016) speak of an OXT-
biased, biobehavioral approach–avoidance principle, with OXT
acting on social salience and reward, as well as dampening veg-
etative responses to social threats and stressors. Furthermore,
OXT may facilitate affiliation by promoting in-group empathy,
cooperation and trust, but also serve the protection from out-
group danger by up-regulating vigilance and defense-motivated
aggression. Therefore, OXT might affect more than one of the
functional systems implicated in psychotic vulnerability by
modulating attachment, social approach, interaction experience
and mentalizing capacity on the one hand and the perception
of aberrant salience and social threat on the other (Olff et al.,
2013; Debbané et al., 2016). Early suggestions of OXT as a ‘natural
antipsychotic’ and evidence from animal studies demonstrating
OXT to counteract excessive mesolimbic dopamine and cortical
hypoglutamatergia led to the assumption that OXT signaling
might be altered in schizophrenia (Macdonald and Feifel, 2012).
However, results from trials using intranasal OXT in patients
with schizophrenia have been mixed, some reporting improve-
ment of positive and negative symptoms or improvement
of specific deficits, while others reported no benefit (Feifel
et al., 2016; Bradley and Woolley, 2017). Accordingly, the role of
endogenous OXT remains inconclusive, with studies reporting
lower (Goldman et al., 2008; Jobst et al., 2014; Aydin et al., 2018) or
higher (Legros et al., 1992; Strauss et al., 2015) cerebrospinal fluid
(CSF) and plasma OXT levels in patients with schizophrenia, as
well as varying associations with symptom load (Goldman et al.,
2008; Kéri et al., 2009; Rubin et al., 2010; Jobst et al., 2014). A small
number of studies report associations of plasma OXT levels with
social cognitive capacity in schizophrenia patients (Goldman
et al., 2008; Walss-Bass et al., 2013; Strauss et al., 2015), the
avoidance of angry faces (Brown et al., 2014) or the perception of
faces as happier (Rubin et al., 2011). OXT measurements in the
absence of a social stimulus seem highly variable, and therefore
stimulus-evoked OXT level changes were considered to be more
reliable (Zak et al., 2005; Kéri and Kiss, 2011). In a single study,
Kéri and coworkers showed OXT responses toward trust-related
interactions to be blunted in schizophrenia patients (Kéri et al.,
2009).
The goal of this study was to compare baseline endogenous
OXT levels as well as OXT level changes induced by social stimuli
between groups of schizophrenia patients and healthy controls
(HCs). To activate the endogenousOXT system,pivotal emotional
scenes from children’s movies like ‘Bambi’ were shown to the
participants. All selected scenes presented situations of bonding
and loss of an attachment figure.Themain hypotheseswere that
schizophrenia patients would (i) differ in OXT baseline levels
when compared to HCs and (ii) show reduced OXT reactivity
in the emotional, but not in a non-emotional control condi-
tion. On an exploratory basis, it was hypothesized that baseline
and induced OXT levels in patients would be associated with
(i) symptom severity, (ii) history of childhood trauma and (iii)
attachment style, which have been linked with OXT dysfunction
in previous studies (Heim et al., 2009; Rilling, 2009).
Materials and methods
Participants
The study was approved by the local ethics committee; subjects
gave written informed consent. Thirty-five in- and outpatients
with paranoid schizophrenia (PS; 23 males), aged 18–65, were
recruited from Charité Universitätsmedizin Berlin, Psychiatric
University Clinic at St. Hedwig Hospital. Diagnosis and symp-
tom severity were confirmed by the treating psychiatrist using
structured clinical interviews for DSM-IV and the Positive and
Negative Syndrome Scale (PANSS). All patients were stabilized,
showing at best mild to moderate symptom load. PS showing
antisocial personality traits were excluded (SCID I; SCID II items
for antisocial personality disorder, German versions). Thirty-
five HC subjects (HC; 23 males), matched for age and verbal IQ,
were recruited by printed and direct verbal advertisement in the
hospital and university (cleaning and nursing staff, students)
and screened with structured interviews (SCID II, MINI; Table 1).
Exclusion criteria for both groups were DSM-IV axis-I or axis-II
disorders (except schizophrenia for patients), hormonal contra-
ception, pregnancy and lactation.HC reporting axis-Imental dis-
orders in their first- or second-degree relativeswere excluded.Of
note, none of the participants manifested postraumatic symp-
toms or PTSD. Participants had to abstain from alcohol/drug
consumption 24 h prior to testing. Menstrual cycle phase of
female subjectswas based on the timeframeof their lastmenses.
Coded as menses/follicular/luteal/menopause/unknown, distri-
bution was n = 2/2/5/1/2 in the PS group, and n = 0/2/3/2/5 in HC
women (χ2 = 4.119, P = 0.390).
Neurocognition
Amultiple choice vocabulary test (Mehrfach-wahl-wortschatztest,
MWT-B) was applied to estimate verbal intelligence. Addition-
ally, a German version of the Auditory Verbal Learning Test
(AVLT) was used as a measure of general cognitive functions
such as multiple verbal memory components and executive
functions. Means of the first five presentations (AVLT(1–5)) were
used for analysis.
Childhood adversity and attachment style
The 28-item form of the Childhood Trauma Questionnaire (CTQ-
SF; Bernstein et al., 2003) was used to assess adverse childhood
experiences.This retrospective self-reportmeasure assesses five
types of maltreatment in separate subscales—emotional abuse,
sexual abuse, physical abuse, emotional neglect and physical
neglect. Each subscale includes five items that are rated on
five-point Likert scales. Psychometric properties of the original
five-factor solution were confirmed for the German translation
(Dudeck et al., 2015) and its usefulness was demonstrated in
schizophrenia patients (Kim et al., 2013). An authorized German
translation of the 16-item Psychosis Attachment Measure (PAM;
Berry et al., 2008) estimated two aspects of insecure attachment,
anxiety and avoidance (eight items each), by self-report, on a
four-point Likert scale. Psychometric properties and factor struc-
ture of the English version are reported from a psychosis sample
(Berry et al., 2008).
Video-stimulated OXT reactivity
For the induction of attachment-related feelings (emotion induc-
tion condition: EMOI), scenes from three children’s movies were
chosen, giving an introduction to the relationship in question
(bonding) and ending with the death of the attachment figure
(loss, empathy with the main character). We chose the films
‘Bambi’ (6 min, 37 s), ‘The Lion King’ (5 min, 44 s) and ‘UP!’
(4 min, 21 s), portraying the loss of a mother, a father and
a beloved wife, respectively. To obtain a reliable and strong
emotion induction effect, all videos were presented consecu-
tively in the same order and confronted participants with the
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Table 1. Demographic data and disease characteristics for schizophrenia patients and HCs
HC Schizophrenia Statistics
Number of participants 35 35
Gender (m/f) 23/12 23/12 1χ2 = 0.000
Age 36.0 ± 10.4 40.4 ± 8.8 2T = 1.882
Verbal IQ 114.1 ± 17.6 107.2 ± 18.0 3U = 471.000
AVLT(1–5) score 10.7 ± 2.0 8.5 ± 2.2 2T = −4.340∗∗∗
Educational years 14.2 ± 2.5 11.9 ± 2.4 3U = 140.000∗∗
CTQ
physical abuse 6.5 ± 3.6 7.2 ± 3.2 3U = 353.000
sexual abuse 5.2 ± 0.9 7.4 ± 4.4 3U = 295.000∗∗∗
emotional abuse 7.7 ± 3.6 10.7 ± 4.1 3U = 238.000∗∗∗
emotional neglect 9.5 ± 3.9 12.0 ± 4.6 3U = 318.000∗
physical neglect 6.8 ± 2.3 8.7 ± 4.1 3U = 286.000∗∗
PAM
anxiety 2.1 ± 0.7 2.5 ± 0.5 3U = 278.000∗∗∗
avoidance 2.0 ± 0.5 2.0 ± 0.4 3U = 507.500
Age at first manifestation - 27.7 ± 8.9 -
Duration of illness - 12.4 ± 8.4 -
Antipsychotic dose (CPZ, [mg])
Total - 386.4 ± 349.7 -
FGA - 64.2 ± 148.6 -
SGA - 304.2 ± 322.0 -
PANSS
positive score4 - 18.2 ± 9.8 -
negative score4 - 19.7 ± 7.5 -
general psychopathology4 - 32.6 ± 11.0 -
1: χ2-Test; 2: T-Test for independent samples; 3: Mann–Whitney-U Test. ∗: P < 0,05; ∗∗ : P < 0,01; ∗∗∗: P< 0.001. Significant results are indicated in bold type. 4: N = 32.
AVLT: Auditory Verbal Learning Test; CPZ: Chlorpromazine equivalent; CTQ: Childhood Trauma Questionnaire; FGA: first generation antipsychotics; PAM: Psychosis
Attachment Measure; PANSS: Positive and Negative Syndrome Scale; SGA: second generation antipsychotics.
attachment played a minor role. A scene from a weather doc-
umentary represented the control condition (CON; 3 min, 37 s).
The CON phase was shorter than the EMOI phase to prevent the
induction of negative emotions like boredom. EMOI and CON
films were balanced regarding their order of appearance (test
version 1: EMOI first; test version 2: CON first). All subjects were
tested between 10 a.m.and 1 p.m. to rule out natural fluctuations
of OXT levels. Subjects were given a 60 min break between
conditions.
After each movie scene, three questions were presented to
the subject: (i) ‘How strongly did you feel with the main charac-
ter?’ (EMPATHY), (ii) ‘Howmuchhave you felt stressed or fearful?’
(AROUSAL) and (iii) ‘How relevant is this scene to your life?’
(RELEVANCE). Subjects were asked to answer on a scale of 1 to
6. In the CON condition, the first question was replaced with (i)
‘How relaxedwere you during the film?’ (RELAXATION), since the
documentary did not feature any empathy-inducing character.
At debriefing after EMOI, participants were asked whether
they would share their thoughts and feelings during the films
with the experimenter. This was rated on a six-point scale
ranging from ‘not at all’ to ‘completely’ (TRUST). Participants
were then asked to take a short note of what they had felt.
A peripheral venous catheter was placed 30 min prior to
testing. Before the first EMOI film and 1 min after the last EMOI
film, as well as before and 1 min after the CON condition, cit-
rated plasma samples were taken, centrifuged immediately and
frozen (−28◦C).The timing of plasma samplingwas based onpro-
tocols using video-based stimulation or trust-related interven-
tions (Barraza and Zak, 2009; Kéri et al., 2009; Munro et al., 2013).
OXT concentrations were determined by radioimmunoassay
(RIA) using solid phase sample extraction by Prof. Dr Rainer
Landgraf, RIAgnosis, Munich (http://www.riagnosis.com). Assay
sensitivity for this method is in the 0.1 pg/ml sample range,
intra- and inter-assay variability is under 10% and no significant
cross-reactivity is reported. Details of extraction method, analy-
sis and validation are reported elsewhere (http://www.riagnosis.
com; Neumann et al., 2013).
Statistical analysis
Normal distribution was determined by Kolmogorov–Smirnov
tests. OXT reactivity was calculated according the following
equation:
EMOI reactivity = [Oxytocin] after EMOI films
[Oxytocin] before EMOI films
CON reactivity = [Oxytocin] after control film
[Oxytocin] before control film
.
OXT reactivities were log-transformed to attain normal dis-
tribution [reactEMOI = log(EMOI reactivity); reactCON = log(CON
reactivity].
Results
Socio-demographic data, illness characteristics, CTQ-SF and
PAM scores are shown in Table 1. PANSS measures for three
patients were not available. Patients scored significantly lower
than healthy subjects in AVLT(1–5) values and educational years
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Table 2. Self-ratings of emotional empathy, arousal or relaxation
experienced during EMOI (sum) and CON, as well as personal rel-
evance of stimuli, and willingness to trustfully share thoughts and
feelings related to EMOI (TRUST), by patients with schizophrenia and
HCs
HCs Schizophrenia Statistical tests
EMOI films
EMPATHY 13.63 ± 2.64 12.26 ± 3.50 U = 474.500
AROUSAL 6.14 ± 3.42 5.80 ± 2.49 U = 612.000
RELEVANCE 9.63 ± 4.09 8.63 ± 3.29 U = 536.500
TRUST 5.18 ± 1.19 4.56 ± 1.54 U = 392.500∗
CON film
RELAXATION 4.80 ± 1.05 4.07 ± 1.41 U = 428.500∗
AROUSAL 1.20 ± 0.47 1.67 ± 1.13 U = 479.500∗
RELEVANCE 2.48 ± 1.46 2.51 ± 1.65 U = 529.000
N = 35/35, means, s.d.; Mann–Whitney U test: ∗: P < 0.05; Significant results are
indicated in bold type. EMOI: presentation of emotional films,CON: presentation
of control film.
on all CTQ-SF subscales apart from physical abuse, and more
attachment anxiety on the PAM than controls.
Behavioral data
PS showed significantly lower self-rated RELAXATION and
higher AROUSAL values during the CON film than HC. No group
differences appeared for EMPATHY, AROUSAL or subjective
RELEVANCE related to the EMOI condition, but PS were slightly
less willing to share their thoughts and feelings with the
experimenter (TRUST; Table 2). No significant associations were
detected between TRUST and PANSS total or subscores (all
P > 0.05). Qualitative debriefing information was available from
n = 31 PS and n = 28 HC.Topics differed between groups,while the
emotional focus was reflected by the majority of participants
in both groups (PS/HC: refused answer: 1/0; rational account:
4/1; emotional but impersonal account: 2/7; emotional personal
recollection: 5/10; fear of loss and/or longing for attachment:
14/10; loneliness: 5/0).
Baseline OXT
Baseline OXT levels did not differ significantly between patients
andHCs.Group comparisons of themale and female subsamples
yielded no differences in males but showed significantly lower
OXT levels in female patients compared to female controls
(Table 3). Analysis of covariance (ANCOVA) was performed
with log-transformed baseline OXT levels as the dependent
variable, group and gender as factors and age as a covariate.
There was a significant interaction between group and gender,
F(1,70) = 5.663; P = 0.02, where female PS had lower baseline
OXT levels than all other groups. There were no significant main
effects of diagnosis, gender or age.
OXT reactivity
PS showed significantly higher OXT levels after emotion/em-
pathy induction (EMOI) than before (Wilcoxon test, Z = −2,129,
P = 0.033), but in HC there were no differences before and after
both conditions (EMOI: Z = −1,368, P = 0.171; CON: Z = −0,655,
P = 0.512). Accordingly, PS showed a significantly higher OXT
reactivity during emotion/empathy induction (EMOI) compared
Table 3. Baseline OXT levels and reactivity of endogenous OXT (ratio





5.48 ± 4.50 4.59 ± 3.35 U = 576.000
Males 4.64 ± 3.84 5.38 ± 3.87 U = 218.000
Females 7.10 ± 5.36 3.07 ± 0.96 U = 31.000∗
OXT EMOI
reactivity
0.96 ± 0.38 1.22 ± 0.50 U = 371.000∗
Males 1.01 ± 0.39 1.15 ± 0.42 U = 190.000
Females 0.85 ± 0.34 1.36 ± 0.64 U = 29.000∗
OXT CON
reactivity
1.07 ± 0.55 1.18 ± 0.48 U = 509.000
Males 1.08 ± 0.62 1.13 ± 0.49 U = 225.000
Females 1.04 ± 0.39 1.27 ± 0.47 U = 58.000
N = 35/35, means, s.d.; Mann–Whitney U test: ∗: P < 0.05; Significant results are
indicated in bold type. EMOI: presentation of emotional films,CON: presentation
of control film.
to HC (Table 3). To assess interaction effects between diagnostic
group, gender and sequence of the experiments (version 1
vs version 2), a factorial multivariate analysis of variance
(MANOVA) with logarithmized OXT reactivities (reactEMOI,
reactCON) as dependent variables, and group, gender and test
version as independent factors, followed by post hoc ANOVAs
was run. Homogeneity of variances was confirmed by Box-M
and Levene’s tests (P > 0.05). Partial eta2 (pη2) was used as an
estimate of effect sizes. Significant main effects were found
for group and test version (Table 4). Post hoc ANOVA revealed a
significant effect of diagnostic group for reactEMOI, but not for
reactCON, reactEMOI being significantly higher in PS, compared
to HC. A significant effect of test version was found for the CON
condition, but not for EMOI. ReactCON was significantly higher
when CON was shown first. There were neither statistically
significant interactions between group and gender or test
version, nor between gender and test version, and no significant
main effect of gender was found (Table 4).
Of note, the effect of diagnostic group on reactEMOI was
not altered by inclusion of baseline OXT levels as a covariate
(F[2,61] = 3.381, P = 0.041, pη2 = 0.10; post hoc: F[1,62] = 6.386,
P = 0.014, pη2 = 0.14).
Correlation analyses
On an exploratory basis, Spearman rank-order correlation
coefficients served to assess the relationship between baseline
OXT levels, OXT reactivities and socio-demographic and illness
characteristics as well as measures of early adversity and
attachment style.
Significant associations of baseline OXT, and OXT changes
to EMOI or CON scenes with age, verbal IQ, AVLT(1–5) scores
or educational years could not be determined. There were no
significant correlations of baseline OXT, EMOI or CON reactivity
with any of the film behavioral questions (all P > 0.05).
A moderate negative correlation of baseline OXT and EMOI
reactivity, but not CON reactivity, appeared in the PS group
(rs = −0.417, P = 0.013), but did not reach significance in HC
(rs = −0.304, P = 0.076), indicating that low OXT levels correlated









ed. Bibliothek user on 31 M
ay 2019
Speck et al. 113
Table 4. Group comparison of endogenous OXT’s reactivity (logarithmized ratio OXT after/before film presentation) in schizophrenia patients
and HCs related to the presentation of emotional vs control films





















































N = 35/35; MANOVA with logarithmically transformed OXT reactivities in the emotional films (reactEMOI) and in the control film (reactCON) as dependent variables;
factors: group (HC/SZ), gender and test version (emotional films followed by control film/control film followed by emotional film). F[df], Effect size (pη2), ∗ : P < 0.05;∗∗: P < 0.01. Significant results are indicated in bold type.
Therewas no significant association of PANSS subscales with
baseline OXT levels or EMOI reactivity (all P > 0.05), but there
was a moderate negative association of OXT CON reactivity
with PANSS ‘general psychopathology’ scores (rs[32] = −0.460,
P = 0.008). No significant associations were found between
baseline OXT levels or reactivity and antipsychotic dose or
duration of illness in PS or male and female PS subgroups (all
P > 0.05).
No associations were found between baseline OXT, OXT reac-
tivities and attachment measures (PAM anxiety and avoidance)
or CTQ-SF total scores and subscales in both groups, even when
analyzed separately by gender. When subjects with minimal vs
low, moderate or severe childhood adversity (according to the
cutoffs by Bernstein et al., 2003) were compared, no significant
differences in baseline OXT or OXT reactivity were observed in
either group (all P > 0.05).
Discussion
Results were partially consistent with our hypotheses: (i) base-
line OXT levels were significantly lower in female patients than
in healthy females; (ii) OXT reactivity during emotional films,
but not during control films, was significantly higher in patients
compared to controls and (iii) OXT reactivity during the control
video, but not during emotional films, negatively related to
PANSS ‘general psychopathology’ scores.
Our data suggest significantly lower baseline OXT levels in
female patients than in healthy women, whereas no respective
differences were found between male controls and male
patients. Decreased baseline OXT levels have been reported in
mixed samples of patients with schizophrenia with (Goldman
et al., 2008) or without (Aydin et al., 2018) neuroendocrine
dysfunction, and in males with schizophrenia (Jobst et al.,
2014), while other studies reported elevated OXT levels in male
schizophrenia patients (Legros et al., 1992) or in samples of
more than 70% males (Walss-Bass et al., 2013; Strauss et al.,
2015) compared to HCs. No group differences (Rubin et al., 2010)
and no significant group x gender interactions were reported,
when medicated (Rubin et al., 2014) or unmedicated (Rubin et al.,
2013) first episode patients were each compared to HCs. Studies
analyzing CSF estimated higher (Beckmann et al., 1985) or similar
(Sasayama et al., 2012) OXT levels in patients vs HCs. Current
evidence regarding alterations of non-induced OXT levels in
psychoses is not conclusive yet and difficult to interpret due
to methodological issues; gender-specific differences were not
regularly considered. Of note, comparing depressed individuals
with HCs, reduced baseline OXT was found in females, but not
inmales (Ozsoy et al., 2009), and results were suggested to reflect
the complex interplay between OXT and gonadal hormoneswith
a higher sensitivity of the female OXT system to the effects of
stress (Ozsoy et al., 2009).
In addition, a stronger influence of antipsychotic medication
on OXT pathways in female patients could be discussed. Animal
studies point to a direct influence of antipsychotic drugs on OXT
pathways and release (Uvnäs-Moberg et al., 1992; Kiss et al., 2010),
though human clinical evidence is still inconclusive (Beckmann
et al., 1985; Sasayama et al., 2012). More likely, antipsychotics
cause menstrual cycle irregularities (Murke et al., 2011) and
thusmight indirectly suppress physiological OXT fluctuations by
altering the estrogen-dependent regulation of the OXT-system
(Gimpl and Fahrenholz, 2001). However, some studies did not
find cycle-dependent variations of OXT levels in both female
patients and healthy women (Rubin et al., 2010, 2011), and there
were no associations between OXT measures and antipsychotic
dose in our study. Altogether, the topic of neuroleptic effects on
the oxytocinergic system including possible interactions with
gender remains to be further explored.
OXT reactivity during emotional films, but not during control
films, was significantly higher in patients compared to con-
trols. Again, this difference was most evident in females. To
eliminate the possibility of the analysis having been skewed
by differing baseline OXT levels between groups, we conducted
a second analysis using baseline OXT as a covariate, which
did not affect our results. To our knowledge, there is only one
other study of induced peripheral OXT levels during social inter-
action in schizophrenia (Kéri et al., 2009), reporting a blunted
OXT response in patients compared to controls after sharing a
secret with the experimenter. Compared to an experimental set-
ting that probably leads to rather variable emotional responses,
movie stimuli in the present study can be considered to reli-
ably elicit strong attachment-related emotions, which was con-
firmed for both groups by personal debriefing. However, while
female patients in our study showed increasing OXT levels dur-
ing the experiment, a decrease was found in healthy women.
This contrasts findings in healthy individuals showing OXT level
increases in subjects viewing emotionally-laden movie scenes
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a modest rise of plasma OXT levels in females during a film’s
bonding scene, but its significant decrease during an abandon-
ment scene (Munro et al., 2013). Our experimental setting did not
allow for differentiation of bonding and abandonment effects,
as each emotional video clip contained both a bonding and an
abandonment phase. Therefore, personally salient aspects of the
film may have differed between diagnostic groups and led to
different physiological reactions, with patients more frequently
reporting an unfulfilled desire for relationship or feelings of
solitude at debriefing, stating that attachment figures like the
ones shown in the films were what they ‘never had’. Healthy
persons, who were more likely to have experienced close rela-
tionships, might have resonated more strongly with the fear of
abandonment and loss. Alternatively, the ‘tend and befriend’
model (Taylor et al., 2000) suggests an OXT release in response to
stressors including social loss or threats thereof, thus increasing
sensitivity and affiliative motivation (Gimpl and Fahrenholz,
2001; Onaka, 2004; Bartz et al., 2011). This reaction type was
found to be more prominent in women (Taylor et al., 2000, 2010).
As schizophrenia patients report higher personal distress when
confronted with others in need, a higher susceptibility to con-
tagion with negative emotions and reduced emotion regulation
capacity (Lehmann et al., 2014), film scenes of bonding and loss
might cause an exaggerated experience of social stress and elicit
‘tend and befriend’ responses. Studies conducted in individuals
suffering from depression or emotional distress suggest not only
gender-specific reductions of baseline OXT (Ozsoy et al., 2009),
but also a dysregulated (Parker et al., 2010) or more variable pul-
satile OXT release (Cyranowski et al., 2008). Higher OXT increases
have been shown in response to relational stress (Tabak et al.,
2011) and in the course of an affiliation-focused imagery session,
and might be related to interpersonal dysfunction (Cyranowski
et al., 2008). Of note, attachment-related stimuli might be more
effective in eliciting OXT responses than general stress (Cyra-
nowski et al., 2008; Tabak et al., 2011).
Patients’ increased vigilance toward social threat may addi-
tionally stimulate OXT release (De Dreu and Kret, 2016). Brown et
al. (2014) demonstrated a stronger tendency to avoid angry faces,
as well as more severe psychotic symptoms, in schizophrenia
patients with higher baseline OXT levels. Accordingly, patients
in our study may have been more susceptible to the induction
of fear and distress, thus exhibiting a measurable difference
in OXT release compared to controls. Consistent with previous
studies in healthy subjects, this effect was more prominent in
females (Barraza and Zak, 2009; Taylor et al., 2010). The fact
that self-ratings of perceived arousal and personal relevance
of stimuli did not correspond to OXT increases during EMOI
may be explained by the characteristic discrepancy between
autonomous arousal and experiential aspects of emotion in
schizophrenia (Kring and Neale, 1996).
Although no significant associations were observed between
OXT measures and self-rated attachment styles in patients
in this study, attachment anxiety was significantly more
pronounced in patients than in controls. Insecure attachment
styles have been associated with both higher stress responses
and lower mean OXT levels compared to securely bound
healthy subjects (Pierrehumbert et al., 2012). OXT increases in
response to attachment- or trust-related stimuli were found
to be most prominent in individuals with insecure attachment
representations (Kiss et al., 2011; Krause et al., 2016). In a similar
vein, our patient group scored significantly higher than HCs
in almost every CTQ subscale, but no associations with OXT
levels and OXT reactivities could be determined, even if gender-
specific aspects and the differential impact of different types of
traumawere considered.Current evidence suggests associations
between adverse childhood experiences and decreased OXT
levels (Heim et al., 2009; Opacka-Juffry and Mohiyeddini, 2012),
possibly as a result of early programming differences in OXT
neurocircuitry. Stress-induced OXT concentrations have been
shown to be either higher in girls having experienced sexual
abuse (Seltzer et al., 2014), or lower in adults with childhood
sexual abuse (Pierrehumbert et al., 2010).Munro et al. (2013) found
OXT increases induced by a film’s bonding scene in females
with dissociative symptoms. However, we cannot exclude that
differences in early childhood experience and attachment style
may have modulated baseline and induced OXT levels in our
patient sample, as very early interactional adversity during sen-
sitive periods of development and disturbances of attunement
and synchrony between child and caregiving persons might not
be assessed by the CTQ (Feldman, 2015). Only two self-rating
instruments and no objective reports were used to examine
attachment representations and childhood adversity. Therefore,
adverse circumstances like prematurity,maternal deprivation or
maternal illness were not accounted for. Moreover, retrospective
reporting might have been biased by paranoid symptoms in
patients. Future research should focus on the relationship
between early experience, attachment insecurity, OXT system
dysregulation and psychotic vulnerabilitymore deeply (Debbané
et al., 2016).
In contrast to schizophrenia patients, we observed decreased
OXT levels after viewing emotional movie scenes in healthy
women. Similarly, decreased OXT levels have been described
as a response to negative emotional stimuli in healthy women
(Turner et al., 1999; Munro et al., 2013). As we also observed signif-
icantly higher baseline OXT levels in female controls compared
to patients, a physiological high activity of the oxytocinergic sys-
temmight have attenuated reactions toward an emotional stres-
sor. However, results regarding an association between periph-
eral OXT, distress or stress-related disorders are still not con-
clusive and ‘protective’ effects might be gender-specific and
dependent on individual biographic factors (Taylor et al., 2010;
Weisman and Feldman, 2013; Olff et al., 2013).
Another finding of our study was a significant main effect
of test version on OXT reactivity, with higher OXT reactivity
during the control stimulus, when it was presented first (test
version 2). This could be due to several reasons. First, the expec-
tation of an experimental manipulation, i.e. stress anticipation,
might have impacted both experimental conditions at baseline
and triggered stress-related OXT secretion (Olff et al., 2013). As
the EMOI stimuli on average caused higher arousal than the CON
condition (Table 2), subtle stress anticipation effects might have
become more obvious in the CON condition when presented
first. Second, subjects in test version 1 had already watched the
EMOI films, which might have lead to subsequent withdrawal
of attention. Third, subjects watching the CON film first could
not know that the later shown EMOI films were emotionally
more impactful. Of note, watching a video about meteorological
research, including diagrams and graphs, might be distressing,
as indicated by significant differences in self-reports of patients
and controls, and drive OXT release.
Our data do not suggest a link between baseline OXT levels
and symptom severity. Previously, inverse relationships with
peripheral OXT were reported for negative (Kéri et al., 2009;
Sasayama et al., 2012; Jobst et al., 2014), social, general (Rubin et
al., 2010) and social-cognitive symptoms (Goldman et al., 2008;
Strauss et al., 2015), while findings regarding positive symptoms
showed mixed results (Legros et al., 1992; Rubin et al., 2010, 2013;
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moderate negative correlation appeared between OXT reactivity
and general psychopathology in the control condition, indi-
cating that subjects with higher OXT reactivity to emotionally
neutral scenes showed less general psychopathology. It can be
speculated that less symptomatic patients were more reflec-
tive, performance-oriented and therefore more prone to stress
anticipation effects. However, no associations were found for
the EMOI condition. Future research might rather focus on the
basic principles of OXT action in schizophrenia like attribution
of social salience,motivation or anxiety in a more parsimonious
experimental approach (Brown et al., 2014).
Limitations
Limitations of our study relate to the concern that peripheral
OXT levels do not reliably reflect central processes. Although
some evidence suggests that stress-related OXT responses can
be confined to hypothalamic or limbic regions while having
no immediate effect in peripheral OXT release, a recent meta-
analysis indicates a positive correlation between peripheral and
CSF OXT level changes when induced by stressors (Valstad et al.,
2017).
Moreover, no standard protocol exists for measuring OXT
in blood samples. Comparability of research is hampered by
the variety of (pre-)analytic procedures, but RIA with sample
extraction is considered the most reliable and best-validated
method (Szeto et al., 2011; Neumann et al., 2013; McCullough
et al., 2013). Though comparability of studies is very restricted,
studies using video-based emotional stimulation and enzyme-
linked immunosorbent assay (ELISA; Barraza and Zak, 2009;
Kéri et al., 2009; Munro et al., 2013) reported results inconsistent
with ours, while RIA-based evidence regarding induced OXT
levels in conditions of emotional distress (Cyranowski et al., 2008;
Ozsoy et al., 2009; Tabak et al., 2011; Seltzer et al., 2014) and in
healthy persons (Turner et al., 1999) might be less conflicting.
However, research using RIA and extracted samples in patients
with schizophrenia is limited to very few studies (Strauss et
al., 2015). Until OXT assaying in humans is not standardized
against methods of references of high sensitivity and specificity,
interpretation of results will remain unsatisfactory (McCullough
et al., 2013).
Another limitation of the study design refers to the fact that
the time course of induced OXT release is not well known. No
pilot testing of OXT peak levels was performed, but previous
studies in healthy adults indicated measurable OXT increases
immediately after 2 min of video-based emotional stimulation
(Barraza and Zak, 2009) or after a short trust-related intervention
(Kéri et al., 2009). To obtain a reliable emotion induction effect on
the one hand and to prevent the induction of negative emotions
like boredomduring the control condition on the other, EMOI and
CON phases were of different duration, and OXT increases dur-
ing the emotional condition could therefore be not specific. In
addition, itmight have requiredmore frequentmeasurements in
timed intervals across emotion induction and recovery phases to
detect group differences regarding the specific temporal dynam-
ics of induced OXT release.
Unfortunately, neither estradiol nor prolactin as potential
mediators of OXT release and their complex interactions were
a focus of this study.
Further limitations refer to a possible influence of social
interaction with the experimenter on OXT reactivity (Kéri et al.,
2009),whichwas not systematically evaluated, the heterogeneity
of the samples regarding menstrual cycle phase and the lack of
control for sexual activity.
Conclusion
This study corroborates previous evidence of an alteration of the
oxytocinergic system in schizophrenia by measuring peripheral
OXT at baseline and after stimulation in an attachment-related
experimental setting. A deeper knowledge of endogenous OXT
regulation, considering its individual and biographic context and
interactions with antipsychotic and mood-stabilizing agents,
may forward a more personalized use of intranasal OXT as a
pharmacological treatment strategy.
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